World Wires · story 5501 · unverified · 1 source(s)

Propanc Biopharma Provides Financial and Corporate Update

Propanc Biopharma reported year-end financial results and announced plans to advance PRP to a Phase 1b clinical study for solid tumors.

Open in the desk

Coverage

• Propanc Biopharma Provides Financial and Corporate Update GlobeNewswire: public companies · tier D · clear net · 2026-09-29 12:30 UTC

What this site indexes